Uri Yablonka
Fortuna: 218 464 $ al 30/06/2026
Fortuna: 218 464 $ al 30/06/2026
Uri Yablonka is Secretary, Director, Chief Business Officer & EVP at Brainstorm Cell Therapeutics, Inc. since 2014.
Formerly, Mr. Yablonka was Vice President-Business Development at ACC International Holdings Ltd. from 2011 to 2014, General Manager & Owner at Mr. Yablonka Ltd., and Senior Partner at Pm Pr Media Consulting Ltd. from 2008 to 2011.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 26/02/2026 | 218.464 ( 1,98 % ) | 218 464 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director/Miembro de la Junta | 06/06/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
ACC International Holdings Ltd.
ACC International Holdings Ltd. Financial ConglomeratesFinance Operates as a holding company with interests in providing oil exploration, engineering, and real estate services | Corporate Officer/Principal | 01/05/2014 |
Pm Pr Media Consulting Ltd. | Corporate Officer/Principal | 01/01/2011 |
Uri Yablonka Ltd. | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
ACC International Holdings Ltd.
ACC International Holdings Ltd. Financial ConglomeratesFinance Operates as a holding company with interests in providing oil exploration, engineering, and real estate services | Finance |
Uri Yablonka Ltd. | |
Pm Pr Media Consulting Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.